×
About 18,772 results

ALLMedicine™ Ankylosing Spondylitis Center

Research & Reviews  7,643 results

Comment on 'Development and validation of an alternative ankylosing spondylitis disease...
https://doi.org/10.1093/rheumatology/keaa688
Rheumatology (Oxford, England); Ortolan A, Ramiro S et. al.

Nov 27th, 2020 - Comment on 'Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable': reply.|2020|Ortolan A,Ramiro S,Bastiaenen C,van der Heijde D,|

The CT Image Changes in Ankylosing Spondylitis from Fracture to Andersson Lesions: A Ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685367
Clinical Interventions in Aging; Bai LL, Du JP et. al.

Nov 27th, 2020 - Ankylosing spondylitis with Andersson lesions is not rare, but its potential pathogenesis and natural course remain unclear. We describe a case of CT image changes in ankylosing spondylitis from fracture to Andersson lesions. A 40-year-old man wit...

STAT3 Phosphorylation Inhibition for Treating Inflammation and New Bone Formation in An...
https://doi.org/10.1093/rheumatology/keaa846
Rheumatology (Oxford, England); Jo S, Won EJ et. al.

Nov 25th, 2020 - Ankylosing spondylitis (AS) is a rheumatic disease characterized by chronic inflammation and bony ankylosis. This study was to evaluate whether a signal transducer and activator of transcription 3 phosphorylation inhibitor (stat3-p Inh) could trea...

Chinese herbal medicine Yanghe decoction for ankylosing spondylitis: A protocol for sys...
https://doi.org/10.1097/MD.0000000000023466
Medicine Xu X, Chen H et. al.

Nov 25th, 2020 - Chinese herbal medicine is a commonly used traditional treatment for ankylosing spondylitis (AS). Among them, Yanghe decoction (YHD) has an obvious effect in relieving the symptoms of AS, but its efficacy is still controversial. The purpose of thi...

Quantitative DCE-MRI: an efficient diagnostic technique for evaluating early micro-envi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685584
BMC Musculoskeletal Disorders; Yang H, Jiang L et. al.

Nov 25th, 2020 - In the management of early inflammatory joint of ankylosing spondylitis (AS), there is a need for reliable noninvasive quantitative monitoring biomarker to closely assess status of synovitis progression. Cognizant to this,studies geared on improvi...

see more →

Guidelines  37 results

2019 Update of the American College of Rheumatology/ Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis ...
https://www.rheumatology.org/Portals/0/Files/AxialSpA-Guideline-2019.pdf
Ward MM,et al

Sep 30th, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). ankylosing spondylitis

2019 Update of the American College of Rheumatology/Spondylitis Association of America/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.

Aug 22nd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...

FDA Approves Samsung Bioepis' HADLIMA™ (adalimumab-bwwd)
https://www.businesswire.com/news/home/20190723006033/en/FDA-Approves-Samsung-Bioepis-HADLIMA%E2%84%A2-adalimumab-bwwd

Jul 23rd, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® i (adalimumab), for the treatment of rheumatoid arthritis, juvenile idiopathic arthr...

FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States
http://www.samsungbioepis.com/en/newsroom/detail/FDA-Approves-ETICOVO-Samsung-Bioepis-Second-Anti-TNF-Medicine.html

Apr 28th, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL® (etanercept), across all eligible indications for the treatment of rheumatoid arthri...

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guidelin...
https://www.rheumatology.org/Portals/0/Files/ACR-AAHKS-Perioperative-Management-Guideline.pdf
Goodman, S.,et al

Jul 31st, 2017 - This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid a.

see more →

Drugs  1,069 results see all →

Clinicaltrials.gov  9,205 results

Comment on 'Development and validation of an alternative ankylosing spondylitis disease...
https://doi.org/10.1093/rheumatology/keaa688
Rheumatology (Oxford, England); Ortolan A, Ramiro S et. al.

Nov 27th, 2020 - Comment on 'Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable': reply.|2020|Ortolan A,Ramiro S,Bastiaenen C,van der Heijde D,|

The CT Image Changes in Ankylosing Spondylitis from Fracture to Andersson Lesions: A Ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685367
Clinical Interventions in Aging; Bai LL, Du JP et. al.

Nov 27th, 2020 - Ankylosing spondylitis with Andersson lesions is not rare, but its potential pathogenesis and natural course remain unclear. We describe a case of CT image changes in ankylosing spondylitis from fracture to Andersson lesions. A 40-year-old man wit...

STAT3 Phosphorylation Inhibition for Treating Inflammation and New Bone Formation in An...
https://doi.org/10.1093/rheumatology/keaa846
Rheumatology (Oxford, England); Jo S, Won EJ et. al.

Nov 25th, 2020 - Ankylosing spondylitis (AS) is a rheumatic disease characterized by chronic inflammation and bony ankylosis. This study was to evaluate whether a signal transducer and activator of transcription 3 phosphorylation inhibitor (stat3-p Inh) could trea...

Chinese herbal medicine Yanghe decoction for ankylosing spondylitis: A protocol for sys...
https://doi.org/10.1097/MD.0000000000023466
Medicine Xu X, Chen H et. al.

Nov 25th, 2020 - Chinese herbal medicine is a commonly used traditional treatment for ankylosing spondylitis (AS). Among them, Yanghe decoction (YHD) has an obvious effect in relieving the symptoms of AS, but its efficacy is still controversial. The purpose of thi...

Quantitative DCE-MRI: an efficient diagnostic technique for evaluating early micro-envi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685584
BMC Musculoskeletal Disorders; Yang H, Jiang L et. al.

Nov 25th, 2020 - In the management of early inflammatory joint of ankylosing spondylitis (AS), there is a need for reliable noninvasive quantitative monitoring biomarker to closely assess status of synovitis progression. Cognizant to this,studies geared on improvi...

see more →

News  767 results

Tofacitinib Effective for Ankylosing Spondylitis in Phase 3
https://www.staging.medscape.com/viewarticle/940709

Nov 9th, 2020 - Patients with active ankylosing spondylitis (AS) experienced rapid clinical response to the oral Janus kinase (JAK) inhibitor tofacitinib (Xeljanz) in a phase 3, randomized, double-blind, placebo-controlled study. Tofacitinib was significantly mor...

Tofacitinib Effective for Ankylosing Spondylitis in Phase 3
https://www.medscape.com/viewarticle/940709

Nov 9th, 2020 - Patients with active ankylosing spondylitis (AS) experienced rapid clinical response to the oral Janus kinase (JAK) inhibitor tofacitinib (Xeljanz) in a phase 3, randomized, double-blind, placebo-controlled study. Tofacitinib was significantly mor...

Fast Five Quiz: Ankylosing Spondylitis Signs and Symptoms
https://reference.medscape.com/viewarticle/932588_4

Jul 1st, 2020 - The age of onset of AS is usually from the late teens to 40 years. Onset in persons older than 50 years is unusual, although diagnosis of mild or asymptomatic disease may be made at a later age. Insidious onset of low back pain is the most common ...

Fast Five Quiz: Ankylosing Spondylitis Signs and Symptoms
https://reference.medscape.com/viewarticle/932588_1

Jul 1st, 2020 - Ankylosing spondylitis (AS) is a chronic, multisystem inflammatory disorder primarily affecting the axial skeleton and sacroiliac joints. AS is one of the seronegative spondyloarthropathies, which are multisystem inflammatory diseases that affect ...

Fast Five Quiz: Ankylosing Spondylitis Signs and Symptoms
https://reference.medscape.com/viewarticle/932588

Jul 1st, 2020 - Ankylosing spondylitis (AS) is a chronic, multisystem inflammatory disorder primarily affecting the axial skeleton and sacroiliac joints. AS is one of the seronegative spondyloarthropathies, which are multisystem inflammatory diseases that affect ...

see more →

Patient Education  51 results see all →